Skip to main content
SpringerLink
Log in

Akuter Harnverhalt bei Männern: Die Wirksamkeit von Alpha-Blockern beim Katheterauslassversuch nach Harnverhalt

Acute urinary retention in men: efficacy of alpha-blockers in catheter removal after urinary retention

  • Evidenzbasierte Medizin
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Agrawal MS, Yadav A, Yadav H, Singh AK, Lavania P, Jaiman R (2009) A prospective randomized study comparing alfuzosin and tamsulosin in the management of patients suffering from acute urinary retention caused by benign prostatic hyperplasia. Indian J Urol 25(4):474–478

    Article  PubMed  PubMed Central  Google Scholar 

  2. Andersson KE, Gratzke C (2007) Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol 4(7):368–378

    Article  CAS  PubMed  Google Scholar 

  3. Annemans L, Cleemput I, Lamotte M, McNeill A, Hargreave T (2005) The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis. BJU Int 96:566–571

    Article  PubMed  Google Scholar 

  4. Bansal A, Arora A (2017) Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis. Neurourol Urodyn 36(7):1757–1762

    Article  CAS  PubMed  Google Scholar 

  5. Duan Y, Grady JJ, Albertsen PC, Wu HZ (2018) Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Pharmacoepidemiol Drug Saf 27(3):340–348

    Article  CAS  PubMed  Google Scholar 

  6. Emberton M, Anson K (1999) Acute urinary retention in men: an age old problem. BMJ 318:921–925

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Fisher E, Subramonian K, Omar MI (2014) The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006744.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  8. Holtgrewe HL, Valk WJ (1962) Factors influencing the mortality and morbidity of transurethral prostatectomy. J Urol 87:450–459

    Article  CAS  PubMed  Google Scholar 

  9. Hua LX, Wu HF, Sui YG, Chen SG, Xu ZQ, Zhang W et al (2003) Tamsulosin in the treatment of benign prostatic hyperplasia patients with acute urinary retention. Zhonghua Nan Ke Xue 9(7):510–511

    PubMed  Google Scholar 

  10. Kara O, Yazici M (2014) Is the double dose alpha-blocker treatment superior than the single dose in the management of patients suffering from acute urinary retention caused by benign prostatic hyperplasia? Urol J 11(3):1673–1677

    PubMed  Google Scholar 

  11. Kumar S, Tiwari PD, Ganesamoni R, Singh SK (2013) Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention. Urology 82(1):171–175

    Article  PubMed  Google Scholar 

  12. Lee KS, Lim KH, Kim SJ, Choi HJ, Noh DH, Lee HW, Cho MC (2011) Predictors of successful trial without catheter for postoperative urinary retention following non-urological surgery. Int Neurourol J 15(3):158–165

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Chen CL, Tsui KH (2018) Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction. Bmc Geriatr 18(1):15

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lucas MG, Stephenson TP, Nargund V (2005) Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU Int 95(3):354–357

    Article  CAS  PubMed  Google Scholar 

  15. Maldonado-Ávila M, Manzanilla-García HA, Sierra-Ramírez JA, Carrillo-Ruiz JD, González-Valle JC, Rosas-Nava E, Guzman-Esquivel J, Labra-Salgado IR (2014) A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth. Int Urol Nephrol 46(4):687–690

    Article  PubMed  CAS  Google Scholar 

  16. McNeill SA, Daruwala PD, Mitchell ID, Shearer MG, Hargreave TB (1999) Sustained-release alfuzosin and trial without catheter after acute urinary retention: A prospective, placebo-controlled. [comment. BJU Int 84(6):622–627

    Article  CAS  PubMed  Google Scholar 

  17. McNeill SA, Hargreave TB, Members of the Alfaur Study Group 2004 (2004) Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol 171(6 Pt 1):2316–2320

    Article  CAS  PubMed  Google Scholar 

  18. McNeill SA, Hargreave TB, Roehrborn CG, Alfaur Study Group 2005 (2005) Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a doubleblind placebo-controlled study. Urology 65(1):83–89 (discussion 89–90)

    Article  CAS  PubMed  Google Scholar 

  19. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 141:243–247

    Article  CAS  PubMed  Google Scholar 

  20. Melchior J, Valk WJ, Foret JD, Mebust WK (1974) Transurethral prostatectomy in the azotemic patient. J Urol 112:643–646

    Article  CAS  PubMed  Google Scholar 

  21. Michel MC, Vrydag W (2006) Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147(Suppl 2):88–119

    Article  CAS  Google Scholar 

  22. Murray K, Massey A, Feneley RC (1984) Acute urinary retention a urodynamic assessment. Br J Urol 56:468–473

    Article  CAS  PubMed  Google Scholar 

  23. Niël-Weise BS, van den Broek PJ (2005) Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004201.pub2

    Article  PubMed  Google Scholar 

  24. Oelke M, Gericke A, Michel MC (2014) Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms. Expert Opin Drug Saf 13(9):1187–1197

    Article  CAS  PubMed  Google Scholar 

  25. Oelke M, Höfner K, Berges RR, Jonas U (2002) Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern – Grundlagen und klinische Ergebnisse. Urologe A 41(5):425–441

    Article  CAS  PubMed  Google Scholar 

  26. Oelke M, Speakman MJ, Desgrandchamps F, Mamoulakis C (2015) Acute urinary retention rates in the general male population and in adult men with lower urinary tract symptoms participating in pharmacotherapy trials: a literature review. Urology 86(4):654–665

    Article  PubMed  Google Scholar 

  27. Omar MI, Lam TB, Alexander CE, Graham J, Mamoulakis C, Imamura M et al (2014) Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP). BJU Int 113(1):24–35. https://doi.org/10.1111/bju.12281

    Article  PubMed  Google Scholar 

  28. Prieto L, Romero J, Lopez C, Ortiz M, Pacheco JJ (2008) Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia. Urol Int 81(1):66–71

    Article  CAS  PubMed  Google Scholar 

  29. Roehrborn CG, Schwinn DA (2004) Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 171(3):1029–1035

    Article  CAS  PubMed  Google Scholar 

  30. Roehrborn CG, Bruskewitz R, Nickel GC, Glickman S, Cox C, Anderson R et al (2000) Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS study group. Eur Urol 37:528–536

    Article  CAS  PubMed  Google Scholar 

  31. Roehrborn CG, McConnell JD (2002) Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (Hrsg) Campbell’s Urology, 8. Aufl. Bd. 2. Saunders, Philadelphia, London, New York, S 1297–1336

    Google Scholar 

  32. Schulman CC (2001) Long-term aspects of medical treatment of BPH. Eur Urol 40(Suppl 3):8–12

    Article  CAS  PubMed  Google Scholar 

  33. Schwinn DA, Roehrborn CG (2008) Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol 15(3):193–199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Shah T, Palit V, Biyani S, Elmasry Y, Puri R, Flannigan GM (2002) Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention. Eur Urol 42(4):323–332

    Article  Google Scholar 

  35. Standardisation Steering Committee ICS and the ICS Working Group on Terminology for Male Lower Urinary Tract & Pelvic Floor Symptoms and Dysfunction, D’Ancona C, Haylen B, Oelke M et al (2019) The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn 38(2):433–477

    Article  Google Scholar 

  36. Tae BS, Jeon BJ, Choi H, Cheon J, Park JY, Bae JH (2019) Alpha-blocker and risk of dementia in patients with benign prostate hyperplasia: a nationwide population-based study using the national health insurance service database. J Urol. https://doi.org/10.1097/JU.0000000000000209

    Article  PubMed  Google Scholar 

  37. Taube M, Gajraj H (1989) Trial without catheter following acute retention of urine. Br J Urol 63(2):180–182

    Article  CAS  PubMed  Google Scholar 

  38. Tibung MJB, Tiong HY, Macalalag M, Liew L, Li MK (2006) Alfuzosin XL prior to trial off catheter after acute urinary retention: early results from a randomized, double-blinded, placebo-controlled trial. Int J Urol 13(Suppl 1):35

    Google Scholar 

  39. Tiong HY, Tibung MJ, Macalalag M, Li MK, Consigliere D (2009) Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia. Urol Int 83(1):44–48

    Article  CAS  PubMed  Google Scholar 

  40. Verhamme KM, Dieleman JP, van Wijk MA, Bosch JL, Stricker BH, Sturkenboom MC (2005) Low incidence of acute urinary retention in the general male population: the triumph project. Eur Urol 47(4):494–498

    Article  CAS  PubMed  Google Scholar 

  41. Yamada S, Ito Y (2011) Alpha(1)-adrenoceptors in the urinary tract. Handb Exp Pharmacol 202:283–306

    Article  CAS  Google Scholar 

  42. Zeif HJ, Subramonian K (2009) Alpha blockers prior to removal of a catheter for acute urinary retention in adult men. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006744.pub2

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Urologie und Nierentransplantation, Martin-Luther-Universität, Ernst-Grube-Straße 40, 06120, Halle/Saale, Deutschland

    S. Mühlstädt FEBU

  2. UroEvidence, Deutsche Gesellschaft für Urologie, Berlin, Deutschland

    S. Mühlstädt FEBU

  3. Arbeitskreis Benignes Prostatasyndrom der DGU, Berlin, Deutschland

    S. Mühlstädt FEBU & M. Oelke

  4. Klinik für Urologie, Kinderurologie und Urologische Onkologie, Prostatazentrum Nord-West, St. Antonius-Hospital, Gronau, Deutschland

    M. Oelke

Authors
  1. S. Mühlstädt FEBU
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Oelke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Mühlstädt FEBU.

Ethics declarations

Interessenkonflikt

S. Mühlstädt und M. Oelke geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Die Zusammenfassung ist eine Übersetzung des Abstracts der Originalpublikation.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mühlstädt, S., Oelke, M. Akuter Harnverhalt bei Männern: Die Wirksamkeit von Alpha-Blockern beim Katheterauslassversuch nach Harnverhalt. Urologe 58, 680–685 (2019). https://doi.org/10.1007/s00120-019-0945-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-019-0945-y

Search

Navigation